Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction

  • Henning Schulze-Bergkamen1Email author,
  • Binje Fleischer1,
  • Marcus Schuchmann1,
  • Achim Weber2,
  • Arndt Weinmann1,
  • Peter H Krammer3 and
  • Peter R Galle1
BMC Cancer20066:232

https://doi.org/10.1186/1471-2407-6-232

Received: 21 July 2006

Accepted: 02 October 2006

Published: 02 October 2006

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
21 Jul 2006 Submitted Original manuscript
12 Aug 2006 Reviewed Reviewer Report - Shiraki Katsuya
17 Aug 2006 Reviewed Reviewer Report - Ruoping TANG
28 Aug 2006 Reviewed Reviewer Report - Brian Gastman
6 Sep 2006 Reviewed Reviewer Report - Roberto R. Rosato
19 Sep 2006 Author responded Author comments - Henning Schulze-Bergkamen
Resubmission - Version 2
19 Sep 2006 Submitted Manuscript version 2
22 Sep 2006 Reviewed Reviewer Report - Ruoping TANG
22 Sep 2006 Reviewed Reviewer Report - Brian Gastman
26 Sep 2006 Reviewed Reviewer Report - Shiraki Katsuya
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
2 Oct 2006 Editorially accepted
2 Oct 2006 Article published 10.1186/1471-2407-6-232

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
First Department of Medicine, Johannes-Gutenberg-University Mainz
(2)
Institute of Pathology, Johannes-Gutenberg-University Mainz
(3)
German Cancer Research Center, Tumor Immunology Program

Advertisement